Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Wendy Kerselaers"'
Autor:
Robert D. McQuade, S. Modell, Wendy Kerselaers, J.P. Kahn, C Werner, J Lissens, R Sanchez, V Ryckmans
Publikováno v:
Pharmacopsychiatry. 42:114-121
Introduction: This study evaluated the safety/ tolerability and effectiveness of aripiprazole titrated-dose versus fixed-dose switching strategies from risperidone in patients with schizophrenia experiencing insufficient efficacy and/or safety/tolera
Autor:
Joao Alberto de Oliveira Campos, Christopher D. Breder, Robert D. McQuade, Wendy Kerselaers, Ronald N. Marcus, Robert M. Berman, William H. Carson, Gilbert L'Italien, John W. Newcomer, Marleen Nys
Publikováno v:
The Journal of Clinical Psychiatry. 69:1046-1056
Objective: Major mental disorders are associated with an increased risk for obesity-related cardiovascular mortality, leading to interest in risk-reduction approaches that target weight and risk-related plasma lipids, including use of antipsychotic a
Autor:
Ralph W. Richter, Sanjiv K. Sharma, Stephen Kaplita, Robert M. Berman, Wendy Kerselaers, Christopher H. van Dyck, Joel Ross, Niels Andreasen, Jesse M. Cedarbaum, Mark Brody, Stephen Salloway, Craig Curtis, Vlad Coric
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
W. Wolfgang Fleischhacker, Delphine Hennicken, W. Landsberg, Patricia Dewaele, Jean-Pierre Olié, Wendy Kerselaers, Robert D. McQuade, Jean-Yves Loze, Martti E. Heikkinen
Publikováno v:
The international journal of neuropsychopharmacology. 13(8)
Clozapine is associated with significant weight gain and metabolic disturbances. This multicentre, randomized study comprised a double-blind, placebo-controlled treatment phase of 16 wk, and an open-label extension phase of 12 wk. Outpatients who met
Autor:
Bruno Dubois, Steven H. Ferris, Luc Bracoud, Vladimir Coric, Jesse M. Cedarbaum, Howard Feldman, Feng Luo, Christopher H. van Dyck, Chahin Pachai, Joshua D. Grill, Craig Curtis, Wendy Kerselaers, Mark A. Mintun, Mark Brody, Robert M. Berman, Gary Pilcher, Holly Soares, Stephen G. Thein, Thomas Shiovitz, Charles F. Albright, Niels Andreasen, John Seibyl, Stephen Salloway, Susan Colby, Randy C. Dockens, Stephen Kaplita, Hilkka Soininen, Ken Marek
Publikováno v:
Coric, V; Salloway, S; Van Dyck, CH; Dubois, B; Andreasen, N; Brody, M; et al.(2015). Targeting prodromal Alzheimer disease with avagacestat: A randomized clinical trial. JAMA Neurology, 72(11), 1324-1333. doi: 10.1001/jamaneurol.2015.0607. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3cc4c60h
Importance Early identification of Alzheimer disease (AD) is important for clinical management and affords the opportunity to assess potential disease-modifying agents in clinical trials. To our knowledge, this is the first report of a randomized tri
Publikováno v:
European Psychiatry. 24:1-1
Background:Metabolic syndrome - a significant risk factor for cardiovascular morbidity and mortality - is twice as prevalent among psychiatric patients (21-63%) as general populations (20-24%). Although there is an inherent illness-associated metabol
Autor:
Jean Yves Loze, Linda Hanssens, Wendy Kerselaers, Ronald N. Marcus, Gilbert L'Italien, Miranda Pans
Publikováno v:
BMC Psychiatry
BMC Psychiatry, Vol 8, Iss 1, p 95 (2008)
BMC Psychiatry, Vol 8, Iss 1, p 95 (2008)
Background The aim of this paper is to evaluate the effect of antipsychotics for the treatment of schizophrenia in a community based study on sexual function and prolactin levels comparing the use of aripiprazole and standard of care (SOC), which was
Autor:
S. Model, V. Rykmans, Raymond Sanchez, Linda Hanssens, J.Y. Loze, A. Dillenschneider, Wendy Kerselaers, J.P. Kahn
Publikováno v:
European Psychiatry. 23:S111
Background and Aim:To evaluate safety, tolerability and overall effectiveness of a titrated- versus fixed-dose switching strategy from risperidone to aripiprazole in a general practice setting.Methods:This 12-week, multicentre, open-label study inclu